Items Tagged ‘mm-398’

November 26th, 2014

MM-398 Receives Fast Track Designation for Advanced Pancreatic Cancer


The U. S. Food and Drug Administration (FDA) has granted MM- 398 plus 5-fluorouracil (5-FU) and leucovorin a Fast Track designation as a second-line treatment for patients with metastatic pancreatic cancer, based on data from the phase III NAPOLI-1 study that were presented at the 2014 World Congress on Gastrointestinal Cancer in June 2014. MM-398 […]

View full entry

Tags: mm-398, News, Pancreatic Cancer, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer